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Abstract
Background: Standard values for birth weight by gestational age are not available for sub-Saharan Africa, but are
needed to evaluate incidence and risk factors for intrauterine growth retardation in settings where HIV,
antiretrovirals, and other in utero exposures may impact birth outcomes.
Methods: Birth weight data were collected from six hospitals in Botswana. Infants born to HIV-negative women
between 26-44 weeks gestation were analyzed to construct birth weight for gestational age charts. These data
were compared with published norms for black infants in the United States.
Results: During a 29 month period from 2007-2010, birth records were reviewed in real-time from 6 hospitals and
clinics in Botswana. Of these, 11,753 live infants born to HIV-negative women were included in the analysis. The
median gestational age at birth was 39 weeks (1
st quartile 38, 3
rd quartile 40 weeks), and the median birth weight
was 3100 grams (1
st quartile 2800, 3
rd quartile 3400 grams). We constructed estimated percentile curves for birth
weight by gestational age which demonstrate increasing slope during the third trimester and leveling off beyond
40 weeks. Compared with black infants in the United States, Botswana-born infants had lower median birth weight
for gestational age from weeks 37 through 42 (p < .02).
Conclusions: We present birth weight for gestational age norms for Botswana, which are lower at term than
norms for black infants in the United States. These findings suggest the importance of regional birth weight norms
to identify and define risk factors for higher risk births. These data serve as a reference for Botswana, may apply to
southern Africa, and may help to identify infants at risk for perinatal complications and inform comparisons among
infants exposed to HIV and antiretrovirals in utero.
Background
Each year over 4 million infants die in the first four
weeks of life (the neonatal period). Ninety-eight percent
of neonatal deaths take place in the developing world,
and the highest risk is in Africa, where an average of 41
neonatal deaths occur per 1000 live births [1]. Botswana,
a middle-income country in southern Africa, has a well-
developed medical infrastructure where 97% of women
access antenatal care, 94% of births are overseen by a
skilled attendant, and 80% of women access hospital-
based obstetrical care for deliveries [1]. However, neona-
tal mortality in Botswana remains high, estimated at 46/
1000 live births in 2004 [1].
Botswana is in the midst of a generalized HIV epi-
demic, and up to a third of infants are born to HIV-
infected women [2]. HIV infection is associated with
adverse birth outcomes and early infant mortality [3-12].
Although the use of combination antiretroviral drugs for
maternal health and for the prevention of mother-to-
child HIV transmission is likely to reduce overall infant
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[13-15], the use of antiretrovirals (ARVs) has also been
associated with lower birth weights [16-19]. A better
understanding of the links between HIV, ARVs, and
birth outcomes is required, particularly in resource-lim-
ited settings where obstetric and pediatric resources are
often limited [17].
Low birth weight infants (< 2500 grams) are at risk for
early death [20,21]. Weight by gestational age is an
important outcome that controls for effects of prema-
turity and is interpreted as a proxy for intrauterine
growth restriction [20,22-25]. Small for gestational age
infants (birth weight < 10
th percentile for gestational
age) are at risk for complications such as peripartum
asphyxia, birth trauma, hypoglycemia, impaired neurolo-
gical development and perinatal mortality [26-30].
Because birth weights may vary regionally, the creation
of specific norms for birth weight by gestational age in
Botswana may be an important step towards identifying
infants at risk for early death [27,31,32].
In this report we describe birth weight for gestational
age for a large cohort of infants born to HIV-negative
women in 6 hospitals in Botswana. Botswana is well-sui-
ted for development of these norms as the majority of
births occur in hospital settings where information on
birth weight, gestational age, and maternal HIV status is
available. We compare these data with U.S. birth weight
data for black infants with the goal of providing reference
data for assessing birth weight for gestational age for
both HIV-exposed and unexposed infants in Botswana.
Methods
Study population
Birth weight and gestational age were recorded for live
births at six government facilities over a 29 month per-
iod from October 19, 2007 to March 16, 2010. Surveil-
lance started at Princess Marina Hospital in Gaborone,
the largest hospital in Botswana. Surveillance began in
2008 at Scottish Livingstone Hospital in Molepole and
at Broadhurst and Old Naledi clinics in Gaborone. In
2009, surveillance expanded to Deborah Reteif Hospital
in the village of Mochudi in southern Botswana, Ghanzi
Primary Hospital in western Botswana, Letsolathebe
Hospital in Maun in northwestern Botswana, and to
Nyangabgwe Hospital in Francistown, the largest city in
northern Botswana.
Princess Marina Hospital is the largest hospital in
Botswana and serves as a tertiary referral center for the
southern part of the country; the Broadhurst and Old
Naledi clinics are smaller clinics in Gaborone. Scottish
Livingstone Hospital and Debora Reteif hospitals are
district-level referral centers. The hospitals in Francis-
town and Ghanzi serve as referral centers for northern
and western Botswana, respectively.
This study was approved by the Office of Human
Research Administration at the Harvard School of Pub-
lic Health, by the Health Research Development Com-
mittee in Botswana, and by all participating hospitals.
Outcomes and Exclusions
Birth weights were abstracted (JYC, NP) from obstetric
records and delivery registries completed by maternity
nurses. Extracted data included birth weight, infant gen-
der, delivery date, gestational age, maternal age, and
documented HIV status. In the event of multiple gesta-
tions, the outcome of the first-born infant was recorded.
Clinical staff assessed and recorded gestational age at
delivery using last normal menstrual period and fundal
height assessment. Gestational ages are not confirmed
by ultrasound in Botswana’s public hospitals.
Our analyses included live births to HIV-negative
mothers between 26 and 44 weeks of gestation with no
known congenital abnormality. Cases for which a live
birth could not be confirmed (including still-births and
those of unknown status) and births to women of posi-
tive or unknown HIV-status were excluded. Births with
documented congenital abnormalities were also
excluded. Because of concerns regarding data accuracy,
infants with recorded birth weight less than 450 grams
or greater than 6500 grams across all gestational ages
and those with a recorded birth-weight that was 20%
lower than the first percentile or 20% higher than the
ninety-ninth percentile of published distributional
norms of black infants born in the U.S. were also
excluded [25]. This U.S. reference represents a large,
comprehensive dataset and detailed data were available
in the public domain. Outlier weights identified in the
prior step were reviewed by four pediatricians. Values
that the majority judged to be reasonable to exclude or
include were treated accordingly [32]. (See Figure 1.)
Statistical Methods
Smoothed birth weight percentiles for gestational ages
26-44 weeks were estimated using quantile regression
analyses with natural cubic B-spline with knots at weeks
24, 26, 28, 38, 40, 44 [33-35]. Knot selection was deter-
mined based on visual inspection of the fit and distribu-
tional shape compared to published birth weight data
from other settings [31,36-38]. Estimated percentile
curves at gestational ages less than 30 or greater than
43 weeks are not plotted but the data for these extremes
of gestational age were retained in the analysis for mod-
eling purposes. Use of this broader data range in model-
ing provides a more realistic representation of growth
profiles over time. However, the small sample size and,
thus, estimate precision limits the generalizability at
these data extremes. All summary data are presented in
Table 1.
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was used to compare birthweight for gestational age
among girls and boys. Birthweight at each gestational
age was compared with the U.S. median weight for that
gestational age using Wilcoxon signed rank test. All
analyses were performed in SAS 9.2 for UNIX.
Results
The initial dataset (18,997 births) was first restricted to
11,814 live births, born to HIV-negative women, without
congenital abnormality, between 26 and 44 weeks of gesta-
tion. An HIV status was recorded for 94% of mothers in
the initial dataset. Of the excluded outcomes, 5,141 (72%)
were births to HIV-positive women and 1,224 were to
women of unknown HIV status. Among the excluded
births to HIV-negative women, 181 were stillbirths, 175
had a congenital abnormality, 435 had unrecorded birth or
congenital abnormality outcome, and 27 had gestational
age less than 26 or greater than 44 weeks. In addition,
sixty-one outliers were removed as described in the meth-
ods, leaving a total of 11,753 in the analysis dataset (Figure
1). For the final analysis dataset, 8,009 (68%) of captured
births were from Princess Marina Hospital, 1,563 (13%)
from Scottish Livingstone Hospital, 763 (8%) from Nyan-
gabgwe (Francistown), while < 5% (700 or fewer) came
from each of the remaining sites.
Figure 1 Selection of analysis dataset. Analysis set limited to live births without congenital abnormalities born to HIV-negative women;
outliers removed as discussed in methods. * Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight
for gestational age using a United States national reference. BMC Pediatrics 2003;3:10.
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4 4w e e k sa r es h o w ni nT a b l e1 .T h en u m b e ro fi n f a n t s
at each gestational age ranged from 9 at 26 weeks to
2482 at 40 weeks. Among all infants, the median gesta-
tional age at the time of birth was 39 weeks, and the
median birth weight was 3100 (IQR 2800-3400) grams.
Boys were generally heavier than girls at each gestational
age with a median of 3160 (IQR 2850, 3480) grams
compared with 3030 (IQR 2750, 3325) grams (p <
.0001), respectively.
Figure 2 shows estimated percentile curves from 30-43
weeks gestation for 11,627 males and females combined
from the final analysis dataset. These curves are similar
to prior birth weight for gestational age data with
increasing slope during the third trimester and leveling
off beyond 40 weeks [25,39].
Figure 3 shows percentile curves constructed from the
Botswana dataset superimposed with curves for U.S.-
born black infants [25]. Observation of the curves and
the data (Table 1) suggest that Botswana-born infants
tended to be larger than U.S.-born infants after shorter
gestation (< 34 weeks) and smaller than U.S. born
infants after longer gestation (≥ 34 weeks). These
observed differences are significant at weeks 27-31 and
weeks 37-42 (p ≤ .04, Table 1).
Table 2 shows weight by percentile for gestational age.
The 10
th percentile for U.S. data is shown for
comparison. The 10
th percentile (the standard cut-off
for small for gestational age) values are observed to be
higher for pre-term babies in Botswana than for pre-
term U.S.-born babies, but to be similar at and beyond
term.
Discussion
This report describes infant birth weight for gestational
age for the largest cohort of infants born to HIV-nega-
tive women reported from southern Africa. These data
may serve as a reference for identifying infants at risk
for early complications and for assessing potential risk
factors for adverse infant outcomes, including maternal
HIV infection and exposure to antiretrovirals in utero.
These data may be representative for births in Bots-
wana. Based on annual and estimated birth rates for
Botswana, there were 114,620 births over the 29 months
of surveillance [40]. The initial data set included 18,997
or about 17% of recorded births for the period. In addi-
tion, 10.8% of infants in this dataset meet the definition
for low birth weight which is consistent with national
statistics reporting 10% incidence [20]. Although Prin-
cess Marina Hospital, the largest hospital in the country,
contributed the majority of the data, the additional sam-
ple sites were located throughout the country and
included primary sites as well as regional and national
referral centers. Because an estimated 80% of births
Table 1 Distribution of birth weights for gestational age for babies born to HIV-negative women in Botswana
compared with median for babies born to black women in the U.S.
Gestational Age
(weeks)
N Minimum
(grams)
Lower Quartile
(grams)
Median
(grams)
Upper Quartile
(grams)
Maximum
(grams)
U.S. median *
(grams)
Δ Median
(Botswana - U.S.)
p-
value
†
26 9 700 880 930 1230 1680 857 73 .051
27 20 670 1013 1116 1610 2310 977 139 .004
28 29 790 1120 1260 1740 2700 1120 140 .003
29 54 750 1200 1375 1725 2950 1304 71 .015
30 62 860 1390 1660 2180 2990 1525 135 .002
31 71 810 1535 1815 2630 3300 1804 11 .032
32 119 800 1680 2085 2730 3440 2084 0.6 .099
33 162 1170 2055 2410 2790 3790 2358 52 .370
34 268 1380 2100 2510 2928 3850 2571 - 61 .095
35 394 1180 2320 2700 3060 4200 2733 - 33 .172
36 687 1470 2560 2850 3115 4335 2870 - 20 .164
37 1056 1790 2690 2960 3240 4680 3014 - 53 < .001
38 1758 1900 2820 3060 3330 4550 3158 - 98 < .001
39 2340 1890 2890 3130 3405 5150 3277 - 147 < .001
40 2482 1960 2970 3220 3500 4920 3356 - 135 < .001
41 1357 1980 3000 3290 3600 5000 3399 - 109 < .001
42 746 2000 3000 3300 3610 5080 3346 - 45 .016
43 125 2300 3000 3280 3540 4405 3316 - 35 .492
44 14 2680 3100 3345 3700 4785 3328 16 .583
* Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference.
BMC Pediatrics 2003;3:10.
† Wilcoxon signed rank test.
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Page 4 of 8Figure 2 Percentile curves for birth weights among babies born to HIV-uninfected women in Botswana, by gestational age. Percentiles
using a B-spline with knots at 24, 26,28,38,40,44 weeks. Actual birth weight data plotted.
Figure 3 Percentile curves for Botswana- compared to U.S.- born black babies. Percentiles using a B-spline with knots at 24, 26,28,38,40,44
weeks (black); published percentiles for black U.S.-born babies shown in gray*. * Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly
continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatrics 2003;3:10.
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Page 5 of 8occur in healthcare facilities, institutional deliveries
should approximate population norms. Those 20% of
births that were not captured may represent a combina-
tion of rural, poorer women who cannot readily access
healthcare as well as more affluent women who access
private clinics.
Birth weight monitoring is complicated in countries
where the majority of births occur outside healthcare
facilities. For most developing countries, birth weight
data are collected via annual Demographic Health Sur-
vey records and birth weight for gestational age is gen-
erally unavailable [20,41]. Institutional birth weight data
from Botswana offer a more reliable representation of
population norms compared to many other developing
country settings since 80% of women access hospital-
based obstetrical and neonatal care [1]. Data from hos-
pital-based deliveries in Botswana may therefore be use-
ful to other countries in southern Africa.
The Botswana-born infants had higher average birth
weights pre-term (statistically significant at 27-31 weeks)
and lower birth weights at term (statistically significant
at 37-42 weeks) than U.S.-born infants in the referent
dataset. Several studies have explored the potential inac-
curacies of gestational age dating by last menstrual per-
iod. Dating is often inaccurate due to recall bias,
variable menstrual cycles, and misinterpretation of
bleeding at the time of embroyo implantation. The sum-
mation of these errors results in underestimation of pre-
maturity (thus higher birth weights pre-term) and
overestimation of post-dates (thus lower birth weights
post-term) [42-46]. Distributions around term tend to
be less affected by this variation, in part due to larger
sample sizes. Among women in the analysis dataset who
had antenatal clinic visit information (~50%), 98% had
attended an antenatal clinic at least once, which may
increase the reliability of the dating. Both datasets esti-
mated gestation age based on last menstrual period, but
it is likely that the larger numbers in the U.S. dataset
improved precision. Our sample sizes exceeded 100
between 32-41 weeks and thus we have the most confi-
dence in these numbers. It is also possible that Bots-
wana-born children have lower birth weight at term
than U.S.-born black infants due to ethnic and/or racial
variability of third trimester birth weight for gestational
age [25,27,32] or due to environmental differences.
Because Botswana-born term babies were smaller than
U.S.-born babies, the 10
th percentile cut-offs were lower.
By convention, the 10
th percentile is the cut-off to
define small for gestational age [47]. Additional research
will be required to assess whether infants at highest risk
are those below the 10
th percentile or if in this setting a
larger proportion of infants are at risk for early
mortality.
There are several limitations to these data. Reported
data were collected from six different hospitals, however
68% of the data were from Princess Marina Hospital, a
tertiary referral site. These women may represent a
wealthier urban population, as well as women referred
with complicated pregnancies. In addition, these data
were not restricted to singleton births, thus potentially
skewing the data towards lower birth weights. Third,
estimated gestational age may be inaccurate when esti-
mated from last menstrual period [42,45]. We attempted
t oc o r r e c tt h ed a t ab ye x c l u d i n gi m p l a u s i b l eb i r t h
weights at each gestational age, and by restricting the
dataset to include only infants from 26 to 44 weeks
Table 2 Estimated birth weight percentile by gestational age for babies born to HIV-negative women in Botswana
Estimated birth weight percentile (grams) by gestational age
Gestation age (weeks) N 3
rd 5
th 10
th 25
th 50
th 75
th 90
th 95
th 10
th U.S.*
30 62 946 1042 1170 1380 1693 2255 2699 2840 980
31 71 1067 1179 1318 1553 1915 2475 2895 3038 1188
32 119 1214 1336 1485 1740 2130 2664 3054 3200 1419
33 162 1384 1509 1670 1936 2333 2822 3179 3330 1616
34 268 1574 1697 1866 2135 2520 2950 3277 3433 1849
35 394 1777 1891 2067 2332 2688 3055 3356 3517 2070
36 687 1979 2082 2260 2517 2834 3146 3427 3590 2248
37 1056 2165 2258 2433 2680 2960 3230 3500 3663 2439
38 1758 2313 2405 2570 2810 3065 3320 3588 3747 2632
39 2340 2409 2510 2660 2900 3152 3420 3697 3848 2750
40 2482 2471 2580 2714 2957 3220 3511 3800 3945 2814
41 1357 2525 2626 2750 2992 3270 3570 3867 4015 2836
42 746 2577 2654 2773 3012 3305 3600 3900 4060 2779
43 125 2629 2670 2788 3021 3330 3610 3910 4088 2770
*1 0
th percentile for U.S.-born black infants. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age
using a United States national reference. BMC Pediatrics 2003;3:10
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Page 6 of 8gestation. Multiple strategies for exclusion of implausi-
ble birth weights have been explored [32,36,39,48-51]
and several strategies were applied to these data. The
method we employed resulted in the best fit for con-
structed growth curves. In addition, the comparison
dataset was taken from published norms for black
infants born in the U.S; however, birth weights by gesta-
tional age for black U.S.-born children are lower than
for other U.S.-born groups [25,39]. In addition, the
reference dataset includes HIV-positive and HIV-nega-
tive mothers. Given that the HIV-prevalence for black
w o m e ni nt h eU . S .i se s t i m a t e da t1 . 1 % ,t h i si su n l i k e l y
to significantly impact the data [52]. Finally, we only
included data for women who had a known negative
HIV status; this limits population-wide applicability, but
will facilitate future comparisons of HIV-exposed infants
with the norms presented in this dataset. This group
will publish the findings for infants born to the HIV-
positive women in a separate manuscript [19].
Conclusions
We present a reference for birth weight for gestational
age for a large sample of infants born to HIV-negative
women in hospitals in Botswana, and demonstrate
lower median term birth weights than reported for
black infants born in the United States. These data
should prove useful for future research investigating
the determinants of neonatal mortality and for asses-
sing the effects of HIV and antiretrovirals on infant
birth weight.
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